Physician profile
Dena J Lichfield
NPI 1952375545
$8,468.44
in general payments reported to CMS, 2019-2025
47 companies · $1,817 in 2025
The $1,817 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $668 · 2021: $1,175 · 2022: $1,022 · 2023: $1,399 · 2024: $1,515 · 2025: $1,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,638 · Education: $93.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,637.50 |
| Education | $93.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,719.41 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $966.92 | 2021-2025 | |
| Lilly USA, LLC | $960.26 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $845.66 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $659.94 | 2019-2025 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $500.38 | 2022-2025 | |
| Exact Sciences Corporation | $373.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $350.85 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $278.04 | 2019-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $265.11 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Grifols USA, LLC | $234.54 | 2019-2025 | Prolastin-C Liquid |
| Amgen INC. | $107.15 | 2019-2025 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $100.28 | 2022-2023 | |
| Allergan, INC. | $69.25 | 2020 | |
| Cranial Technologies, INC | $66.98 | 2021-2025 | Doc Band |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Lichfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.